Mason Capital Management LLC’s Kenneth M Garschina said he wants Grifols SA’s board replaced.Most Read from BloombergRiyadh ...

Mason Capital Management LLC’s Kenneth M Garschina said he wants Grifols SA’s board replaced. The co-founder of the New ...

For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...

La farmacéutica española Grifols SA está en conversaciones con bancos para refinanciar bonos que vencen el próximo año y ...

Grifols (NASDAQ:GRFS) has commenced discussions with banks to refinance its bonds due in 2025, Bloomberg News reported, a day ...

Law firm Araoz y Rueda has been independently engaged by several international and Spanish institutions (the "Clients") holding in aggregate 5.65% of A shares and 3.88% of B shares (including ADRs) in ...

Grifols rejects Brookfield’s €10.5/share offer, signaling undervaluation. Read why GRFS stock is a strong "Buy" despite the ...

JPMorgan lowered the firm’s price target on Grifols (GRFS) to EUR 9.50 from EUR 14 and keeps a Neutral rating on the shares. Don't Miss our Black Friday Offers: Published first on TheFly – the ...

The board of Spanish plasma-based medicines producer Grifols has announced the termination of discussions with Brookfield ...

Barcelona-based Grifols has seen its stock value plummet since January, when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit ...